Secondary prevention of Alzheimer’s dementia: neuroimaging contributions

Secondary prevention of Alzheimer’s dementia: neuroimaging contributions

Abstract Background In Alzheimer’s disease (AD), pathological changes may arise up to 20 years before the onset of dementia. This pre-dementia window provides a unique opportunity for secondary prevention. However, exposing non-demented subjects to putative therapies requires reliable biomarkers for...

Full description

Bibliographic Details
Main Authors: Mara ten Kate, Silvia Ingala, Adam J. Schwarz, Nick C. Fox, Gaël Chételat, Bart N. M. van Berckel, Michael Ewers, Christopher Foley, Juan Domingo Gispert, Derek Hill, Michael C. Irizarry, Adriaan A. Lammertsma, José Luis Molinuevo, Craig Ritchie, Philip Scheltens, Mark E. Schmidt, Pieter Jelle Visser, Adam Waldman, Joanna Wardlaw, Sven Haller, Frederik Barkhof
Format: Article
Language:English
Published: BMC 2018-10-01
Series:Alzheimer’s Research & Therapy
Subjects:
Alzheimer’s disease
Neuroimaging
Secondary prevention
Clinical trials
Online Access:http://link.springer.com/article/10.1186/s13195-018-0438-z

Internet

http://link.springer.com/article/10.1186/s13195-018-0438-z

Similar Items